Award notice Supplies

Antitumoraux

Notice published in French. The AI analysis summarises it for you in your language.

Official notice and documents

Public buyer: CHIREC
Bruxelles (Auderghem)
Place of performance: 1160 Bruxelles (Auderghem), Brussels-Capital
Amount awarded: €977,080 excl. VAT
Planned end of contract: 10 December 2028
likely re-tender around June 2028
Bids received: 3
Procedure: Open procedure
Any company may submit a bid.
Publication: 17 December 2024
Notice language: French

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Antitumoraux

Awarded to

19 lots

Bendamustine injectable
Fluorouracil injectable
Gemcitabine injectable
Vinorelbine injectable
Etoposide injectable
Paclitaxel injectable
Docétaxel injectable
Topotécan injectable
Irinotécan injectable
Trabectédine injectable
Doxorubicine injectable
Epirubicine injectable
Cisplatine injectable
Carboplatine injectable
Oxaliplatine injectable
Témozolomide per os
Capécitabine per os
Erlotinib per os
Anagrélide per os

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below: €269,390
Median: €449,863
A quarter above: €962,736

Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

Contract	Winner	Amount
Fer injectable CHIREC · 7 October 2026	Viatris	€432,640
Antitumoraux per os CHIREC · 16 October 2025	EG Grindeks Kalceks Belgium	€120,203
Époétine alfa CHIREC · 1 April 2025	Sandoz	€303,318
Ranibizumab CHIREC · 17 January 2025	Teva Pharma Belgium	€571,200
Facteurs de stimulation des colonies de granulocytes (G-CSF) CHIREC · 17 December 2024	Teva Pharma Belgium ACCORD HEALTHCARE	€277,997

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 771111-2024.